Welcome To The Haemacure Corporation HUB On AGORACOM
A specialty bio-therapeutics company
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

AGORACOM News Flash

AGORACOM Wire - Wednesday February 15th, 2012

Breaking News ....

Lomiko (LMR: TSX-V) to Complete 43-101 Report on Previous Drilling at the Quatre Milles Graphite Property *CLIENT* Read More

Top Sector Stories ....

Strike Graphite Corp. (TSXV:SRK) Acquires Wagon Graphite Project in Quebec in Vicinity of Timcal's Lac des Iles Graphite Mine *CLIENT* Read More  |  Profile

Strike Graphite goes "Beyond the Press Release"

McLaren Resources (CNSX:MCL) Drills 7.0 Grams Gold Over 7.4 Metres at the TimGinn Property Located Adjacent to the Hollinger Mine *CLIENT* Read More | Watch Beyond the Press Release

DONNER METALS INTERVIEW: David Patterson Discusses the Bracemac-McLeod Mine Development Beyond the Press Release

 AGORACOM Launches GraphiteStocksBlog.com

We're proud to announce the launch of GraphiteStocksBlog.com a website dedicated to the needs of investors and companies in the fast growing Graphite industry.

INAUGURAL GRAPHITE SPONSORS

Message: Live Webcast of Special Meeting of Shareholders on Wednesday, April 9, 2008 at 4 p.m.

Agoraa
Rank: [?]
President
Points: [?]
11204
Rating: [?]
Votes: 30 Score: 4.0
  • Currently 4.0/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Live Webcast of Special Meeting of Shareholders on Wednesday, April 9, 2008 at 4 p.m.

posted on Apr 09, 08 08:22AM

Haemacure Corporation (TSX : HAE), a Montreal-based specialty bio-therapeutics company, will hold its Annual General and Special Meeting of Shareholders on Wednesday, April 9, 2008 at 4 p.m. at The National Club, 303 Bay Street, Toronto, Ontario.

 

Presentation

Mr. Joseph Galli, Chairman and Chief Executive Officer of Haemacure, will report on accomplishments of 2007 and provide an outlook for 2008 and beyond, including a report on Haemacure's clinical programs for its two proprietary, human product candidates, a fibrin sealant and an active, topical hemostatic agent (thrombin).

 

Live Webcast

For those who are unable to attend in person, Haemacure will simultaneously host a live webcast of the presentation with slides, at

http://events.snwebcastcenter.com/haemacure/20080409/

New Message

Please login to post a reply

AGORACOM Quick Tips

Alaskan Junior Gold Co. with Bonanza Grades ... Learn More!

President's D.D.

New feature: Hub Presidents can add important links here.